Vivani Medical, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
Donald Dwyer, Chief Business Officer of Vivani Medical, Inc., reported multiple transactions in common stock on July 28, 2026.
NASDAQ
Lisa Ellen Porter, Chief Medical Officer of Vivani Medical, Inc., reported multiple transactions in common stock on July 28, 2026.
NASDAQ
Anthony Baldor, Chief Financial Officer of Vivani Medical, Inc., reported multiple transactions in common stock on July 28, 2026.
NASDAQ
Truc Le, Chief Operations Officer of Vivani Medical, Inc., reported multiple transactions in common stock on July 28, 2026.
NASDAQ
Adam Mendelsohn, Chief Executive Officer and a Director of Vivani Medical, Inc., reported multiple transactions in common stock on July 28, 2026.
NASDAQ
Daniel Bradbury, a Director of Vivani Medical, Inc., received 7,965 shares of common stock on July 27, 2026.
NASDAQ
Gregg Williams, a Director and 10% owner of Vivani Medical, Inc., purchased 793,650 shares of common stock on July 15, 2026 for $1.26 per share.
NASDAQ
Vivani Medical, Inc. reports that Director August J. Moretti was granted 36,000 non-qualified stock options with an exercise price of $1.22.
NASDAQ
Director Gregg Williams of Vivani Medical, Inc. has acquired stock options as part of an annual grant under the company's Non-Employee Director Compensation Policy.
NASDAQ
Vivani Medical, Inc. reports that Director Alexandra L. Popoff was granted stock options as part of her annual compensation.
NASDAQ
Vivani Medical, Inc. reports an annual stock option grant to Director Daniel Bradbury.
NASDAQ
Vivani Medical, Inc. reports an annual stock option grant to Director Aaron Mendelsohn.
NASDAQ
Gregg Williams, a Director and 10% Owner of Vivani Medical, Inc., acquired 1,587,301 shares of common stock in a private sale for $1.26 per share.
NASDAQ
Form 4: Gregg Williams Buys VANI Stock
Gregg Williams, a Director and 10% Owner of Vivani Medical, Inc., has acquired 1,587,301 shares of common stock in a private sale.
NASDAQ
Director and 10% owner Gregg Williams acquired 1,587,301 shares of Vivani Medical, Inc. common stock for approximately $2 million.
NASDAQ
Vivani Medical Director and 10% owner Gregg Williams acquired 1,575,231 shares of common stock for approximately $1.68 million through private transactions.
NASDAQ
Vivani Medical Director and 10% owner Gregg Williams acquired over 1.35 million shares of common stock in a private transaction for nearly $2 million.
NASDAQ
Vivani Medical's Director and 10% owner, Gregg Williams, significantly increased his beneficial ownership through two private stock purchases totaling over $1.98 million.
NASDAQ
Vivani Medical, Inc. Director Daniel Bradbury was granted 47,212 non-qualified stock options with an exercise price of $1.23, vesting quarterly through December 31, 2026.
NASDAQ
Vivani Medical, Inc. director and 10% owner Gregg Williams was awarded 72,392 non-qualified stock options with an exercise price of $1.23, vesting quarterly through December 31, 2026.
NASDAQ
Vivani Medical Director Aaron Mendelsohn reported an open market purchase of 20,000 shares and disclosed a previously unfiled gift of 20,000 shares.
NASDAQ
Vivani Medical Director and 10% owner Gregg Williams acquired over 1.7 million shares of common stock in private transactions, signaling increased confidence.
NASDAQ
Vivani Medical Director and 10% owner Gregg Williams acquired over 1.7 million shares in private transactions totaling approximately $2 million, increasing his beneficial ownership to 27.89 million shares.
NASDAQ
Vivani Medical, Inc. Director and 10% owner Gregg Williams acquired 3,703,703 shares of common stock for approximately $6 million in a private sale.
NASDAQ
Gregg Williams, a Director and 10% owner of Vivani Medical, Inc., significantly increased his beneficial ownership by purchasing 1,737,764 shares of common stock in two private transactions.
NASDAQ
Vivani Medical Director and 10% owner Gregg Williams increased his beneficial ownership through two private stock purchases totaling over 2 million shares for approximately $2.5 million.
NASDAQ
Vivani Medical, Inc. Director Aaron Mendelsohn was granted 35,135 non-qualified stock options at an exercise price of $1.27 per share as part of the company's non-employee director compensation policy.
NASDAQ
Vivani Medical, Inc. Director and 10% Owner Gregg Williams filed a Form 4 detailing the acquisition of new non-qualified stock options and a clerical adjustment to a previously reported option grant.
NASDAQ
Vivani Medical, Inc. Director Wilford Dean Baker was granted 35,135 non-qualified stock options at an exercise price of $1.27 as part of the company's non-employee director compensation policy.
NASDAQ
Form 4: Vivani Medical Director Daniel Bradbury Reports New Stock Option Grant and Clerical Correction
Vivani Medical, Inc. Director and 10% Owner Daniel Bradbury reported the acquisition of 35,135 non-qualified stock options and a clerical correction to a previously reported option grant, as detailed in a recent SEC Form 4 filing.